$17.02
1.62% day before yesterday
Nasdaq, Dec 27, 10:00 pm CET
ISIN
IL0011595993
Symbol
INMD

Inmode Stock price

$17.02
-2.47 12.67% 1M
-1.04 5.76% 6M
-5.22 23.47% YTD
-5.48 24.36% 1Y
-55.00 76.37% 3Y
-2.49 12.76% 5Y
+10.24 150.85% 10Y
Nasdaq, Closing price Fri, Dec 27 2024
-0.28 1.62%
ISIN
IL0011595993
Symbol
INMD
Sector

Key metrics

Market capitalization $1.44b
Enterprise Value $760.65m
P/E (TTM) P/E ratio 9.20
EV/FCF (TTM) EV/FCF 4.83
EV/Sales (TTM) EV/Sales 1.80
P/S ratio (TTM) P/S ratio 3.40
P/B ratio (TTM) P/B ratio 1.95
Revenue growth (TTM) Revenue growth -15.05%
Revenue (TTM) Revenue $423.75m
EBIT (operating result TTM) EBIT $135.91m
Free Cash Flow (TTM) Free Cash Flow $157.55m
Cash position $684.89m
EPS (TTM) EPS $1.85
P/E forward 9.86
P/S forward 3.50
EV/Sales forward 1.85
Short interest 8.33%
Show more

Is Inmode a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,886 stocks worldwide.

Inmode Stock Analysis

Unlock Scores for Free

Analyst Opinions

7 Analysts have issued a Inmode forecast:

3x Buy
43%
4x Hold
57%

Analyst Opinions

7 Analysts have issued a Inmode forecast:

Buy
43%
Hold
57%

Financial data from Inmode

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Oct '24
+/-
%
424 424
-
100%
- Direct Costs 78 78
-
18%
346 346
-
82%
- Selling and Administrative Expenses 195 195
-
46%
- Research and Development Expense 14 14
-
3%
137 137
-
32%
- Depreciation and Amortization 0.60 0.60
-
0%
EBIT (Operating Income) EBIT 136 136
-
32%
Net Profit 154 154
-
36%

In millions USD.

Don't miss a Thing! We will send you all news about Inmode directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Inmode Stock News

Positive
Seeking Alpha
17 days ago
InMode Ltd. demonstrates impressive net income growth from non-invasive surgical products, with new platforms Define and Envision expected to drive future business growth. The company's innovative technologies in plastic surgery, dermatology, gynecology, and ophthalmology, along with ongoing stock repurchases, make InMode a compelling buy. Strong financials show consistent income growth and sig...
Neutral
PRNewsWire
about 2 months ago
YOKNEAM, Israel , Nov. 6, 2024 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, today announced the participation at the following investor conferences in November and December: UBS Global Healthcare Conference Presenters: Yair Malca, Chief Financial Officer Format: In-person fireside chat moderated by Danielle Antalffy, Senior Equity Ana...
Negative
Seeking Alpha
about 2 months ago
Elevated interest rates continue to hurt InMode's revenue, especially as lease package interest rates haven't fallen yet. Still, future rate cuts could release pent-up demand. InMode continues to buy back shares at a low price, which will boost per-share results. InMode's manufacturing is done in Israel, presenting a risk, but the company has been managing this well despite the war.
More Inmode News

Company Profile

InMode Ltd. designs, develops, manufactures and markets minimally-invasive aesthetic medical products. It also designs, develops, manufactures and markets non-invasive medical aesthetic products that target a array of procedures including permanent hair reduction, facial skin rejuvenation, wrinkle reduction, cellulite treatment, skin appearance and texture and superficial benign vascular and pigmented lesions. The company was founded by Moshe Mizrahy and Michael Kreindel on January 2, 2008 and is headquartered in Yokneam, Israel.

Head office Israel
CEO Moshe Mizrahy
Employees 581
Founded 2008
Website www.inmodemd.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today